Stephens sees strategic fit as TruBridge pops on potential IKS deal

Stephens notes TruBridge’s (TBRG) shares are trading up today following an article published overnight in the Economic Times stating IKS Health is in advanced negotiations to acquire TruBridge for about $600M and a formal announcement is expected in the coming days, citing people aware of the matter. IKS Health is a global company that supports many large health systems across the U.S., helping them reduce administrative, clinical, and operational burdens, which aligns very well with TruBridge’s goals and value-add, in Stephen’s view. The firm has an Equal Weight rating on TruBridge with a price target of $18.